Cargando…

Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study

Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended globa...

Descripción completa

Detalles Bibliográficos
Autores principales: Novais, Catarina, Santos, Joaquim, Alves, Claúdia, Mendonça, Ema, Salgado, João, Lopes, Diogo, Cruz, Ana Margarida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590168/
https://www.ncbi.nlm.nih.gov/pubmed/37868398
http://dx.doi.org/10.7759/cureus.45701
_version_ 1785123943019970560
author Novais, Catarina
Santos, Joaquim
Alves, Claúdia
Mendonça, Ema
Salgado, João
Lopes, Diogo
Cruz, Ana Margarida
author_facet Novais, Catarina
Santos, Joaquim
Alves, Claúdia
Mendonça, Ema
Salgado, João
Lopes, Diogo
Cruz, Ana Margarida
author_sort Novais, Catarina
collection PubMed
description Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended global clinical decision is to refrain from employing CHC in female smokers aged 35 or older. This study aimed to improve contraception prescription for female smokers aged 35-54 in PC. Methods This study was conducted in a Portuguese Family Health Unit (FHU) from October 2021 to August 2022, and it followed the Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0) guidelines and the Plan-Do-Study-Act approach. Female smokers aged 35-54 were included and evaluated in three moments: baseline evaluation (October 2021), intermediate evaluation (February 2022), and post-intervention evaluation (August 2022). Interventions involved educating medical staff, creating patient awareness campaigns, and evaluating contraceptive methods. The established quality-defining goal was to decrease the prevalence of female smokers aged 35 or above using CHC to ≤5%. Results CHC prevalence among smoking women aged 35-54 decreased from 16.4% to 8.5% after nine months of the initial intervention. There was an increase in progestogen-only methods usage over time, from 25.7% to 34.0%. Discussion Despite not fully achieving the predefined goal, interventions led to a substantial reduction of CHC use among smoking women aged 35-54. Collaborative efforts between healthcare professionals and patients played a pivotal role in optimizing care and reducing cardiovascular risk. This study underscores the importance of continuous quality improvement, collaborative interventions, and knowledge updates in Family Medicine practice. While conducted in a single FHU, the intervention’s multidimensional approach holds the potential for broader applicability. Conclusion In the future, healthcare teams should continue to reflect on achieved results, maintain knowledge, and empower patients in contraceptive method choices. The study contributes to improved care quality and highlights the positive impact on medical practice and patient outcomes.
format Online
Article
Text
id pubmed-10590168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105901682023-10-22 Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study Novais, Catarina Santos, Joaquim Alves, Claúdia Mendonça, Ema Salgado, João Lopes, Diogo Cruz, Ana Margarida Cureus Family/General Practice Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended global clinical decision is to refrain from employing CHC in female smokers aged 35 or older. This study aimed to improve contraception prescription for female smokers aged 35-54 in PC. Methods This study was conducted in a Portuguese Family Health Unit (FHU) from October 2021 to August 2022, and it followed the Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0) guidelines and the Plan-Do-Study-Act approach. Female smokers aged 35-54 were included and evaluated in three moments: baseline evaluation (October 2021), intermediate evaluation (February 2022), and post-intervention evaluation (August 2022). Interventions involved educating medical staff, creating patient awareness campaigns, and evaluating contraceptive methods. The established quality-defining goal was to decrease the prevalence of female smokers aged 35 or above using CHC to ≤5%. Results CHC prevalence among smoking women aged 35-54 decreased from 16.4% to 8.5% after nine months of the initial intervention. There was an increase in progestogen-only methods usage over time, from 25.7% to 34.0%. Discussion Despite not fully achieving the predefined goal, interventions led to a substantial reduction of CHC use among smoking women aged 35-54. Collaborative efforts between healthcare professionals and patients played a pivotal role in optimizing care and reducing cardiovascular risk. This study underscores the importance of continuous quality improvement, collaborative interventions, and knowledge updates in Family Medicine practice. While conducted in a single FHU, the intervention’s multidimensional approach holds the potential for broader applicability. Conclusion In the future, healthcare teams should continue to reflect on achieved results, maintain knowledge, and empower patients in contraceptive method choices. The study contributes to improved care quality and highlights the positive impact on medical practice and patient outcomes. Cureus 2023-09-21 /pmc/articles/PMC10590168/ /pubmed/37868398 http://dx.doi.org/10.7759/cureus.45701 Text en Copyright © 2023, Novais et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Novais, Catarina
Santos, Joaquim
Alves, Claúdia
Mendonça, Ema
Salgado, João
Lopes, Diogo
Cruz, Ana Margarida
Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title_full Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title_fullStr Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title_full_unstemmed Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title_short Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
title_sort optimizing contraceptive prescription in smoking women: a quality improvement study
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590168/
https://www.ncbi.nlm.nih.gov/pubmed/37868398
http://dx.doi.org/10.7759/cureus.45701
work_keys_str_mv AT novaiscatarina optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT santosjoaquim optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT alvesclaudia optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT mendoncaema optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT salgadojoao optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT lopesdiogo optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy
AT cruzanamargarida optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy